We’re looking for individuals who have been diagnosed with Stage 4 metastatic breast cancer and are currently taking, or have recently taken TRUQAP® (capivasertib). Participate in a brief and confidential interview to help shape the future of those navigating this journey.

Qualified participants, who complete the interview, will receive compensation for their time and effort. Medical proof of diagnosis will be required.

Determine your eligibility and click on the button below. *Compensation varies by study and will be provided to eligible participants upon completion of study activities.